Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck | 77 |
| PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck | 50 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck | 0 | 6 | 0 | 1 | 1 | 5 | 1 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 72 |
| China | 11 |
| Netherlands | 8 |
| Germany | 7 |
| Vietnam | 7 |
| France | 3 |
| Russia | 3 |
| Australia | 2 |
| Ukraine | 2 |
| Argentina | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 22 |
| Fairfield | 8 |
| Rotterdam | 8 |
| San Ramon | 8 |
| Hanoi | 7 |
| Des Moines | 5 |
| Cambridge | 4 |
| Zhengzhou | 4 |
| Beijing | 2 |
| Chernivtsi | 1 |